Net sales of ESTROSTEP FE decreased $13.9 million, or 58.0%, in the quarter ended December 31, 2007 compared to the prior year quarter. ...
Net sales of ESTROSTEP FE decreased $13.9 million, or 58.0%, in the quarter ended December 31, 2007 compared to the prior year quarter. ...
... newer generic launches include versions of the popular antidepressant Wellbutrin XL, the fentanyl pain patch and an the oral contraceptive Estrostep Fe. ...
s oral contraceptive pill Estrostep Fe. The US Food and Drug Administration approved Barr's abbreviated new drug application for Estrostep Fe tablets, ...
... between Warner Chilcott and Watson Pharma, Watson has launched Tilia Fe, the generic version of Warner Chilcott's oral contraceptive Estrostep Fe. ...
... Inc., on Monday said that Watson has launched Tilia Fe, a generic version of Warner Chilcott's oral contraceptive Estrostep Fe, under a supply agreement ...
O: Quote, Profile, Research) oral contraceptive, Estrostep Fe. Under a supply agreement between the two companies, Warner Chilcott will supply the generic, ...
The generic drugmaker said it would launch its product immediately under the tradename trilegest Fe. Estrostep Fe had annual sales of about $110 million for ...
s contraceptive pill Estrostep. The company will launch the product immediately under the name trilegest Fe. Barr said Estrostep had annual sales of around ...
... Inc.'s Estrostep(R) Fe (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets) oral contraceptive product. ...